quinupristin-dalfopristin has been researched along with sanfetrinem* in 1 studies
1 other study(ies) available for quinupristin-dalfopristin and sanfetrinem
| Article | Year |
|---|---|
Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents.
The antimicrobial activities of trovafloxacin, moxifloxacin, sanfetrinem, quinupristin-dalfopristin, and 14 other antimicrobial agents against 218 Bacteroides fragilis group strains were determined. A group of 10 imipenem-resistant strains were also tested. Imipenem, meropenem, and sanfetrinem had the lowest MICs of all of the beta-lactams. Quinupristin-dalfopristin inhibited all of the strains at 2 microg/ml. Overall, the MICs of trovafloxacin and moxifloxacin for 90% of the strains tested were 1 and 2 microg/ml, respectively. Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteroides fragilis; Fluoroquinolones; Lactams; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Quinolines; Virginiamycin | 1999 |